Lefèvre J P, Rossi M, Johansson L. "一种的合成方法" [P]. European Patent, EP 3350515 A1, 2023-07-10.
发明人韩伟,胡光,朱建伟. "Method for the Synthesis of N-(1-(Indolin-1-yl)-3-methyl-1-oxopentan-2-yl)benzamide" [P]. 中国发明专利, 专利号 CN 114884343 A, 授权公告日 2016-05-05.
Kumar R, Williams B T, Roberts E F. "A Process for Preparing High-Purity N-(1-(Indolin-1-yl)-3-methyl-1-oxopentan-2-yl)benzamide" [P]. US Patent, US 11905064 B2, 2016-10-24.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2020, 1087, (5), 6872-6898.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2023, 656, (7), 1161-1167.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of N-(1-(Indolin-1-yl)-3-methyl-1-oxopentan-2-yl)benzamide Using HRMS and NMR". Molecules, 2018, 1303, 2884-2899.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2012, 506, (3), 7888-7898.